Molecular Diagnostics at the Point of Care Market Research Report 2025: Comprehensive Five-Year Forecasts - Displacing Frontline Test Protocols and Saving Money
Explore the rapid expansion of the Molecular Diagnostics Point of Care market with our in-depth report. Discover how Point of Care testing is revolutionizing healthcare by reducing costs, enhancing outcomes, and tackling Anti-Microbial Resistance. With a five-year market forecast, this report is essential for understanding potential shifts in frontline test protocols. Stay informed and confident in investment decisions with all data available in Excel format. Gain expertise in your organization at no extra cost.
Dublin, June 03, 2025 (GLOBE NEWSWIRE) -- The "Molecular Diagnostics at the Point of Care 2025-2029: By Application, Technology, Place, Product and Country, with Executive Guides and Analysis" has been added to ResearchAndMarkets.com's offering.
Molecular Diagnostics at the Point of Care is on the brink of unprecedented growth, offering transformative changes in healthcare outcomes and cost-efficiency. This burgeoning market segment is being propelled by advancements in technology and increasing demand for rapid, reliable testing solutions available right at the patient's bedside.
Recent data indicates an impressive upward trajectory in market performance, driven in part by major players who are consistently reporting robust growth figures. One of the key catalysts for this surge is the technology's capability to significantly reduce costs while simultaneously enhancing diagnostic outcomes. Importantly, it plays a vital role in combating Anti-Microbial Resistance, presenting a compelling case for its wider adoption.
With a market poised to potentially disrupt traditional testing protocols, stakeholders are keen on understanding both the challenges and future outlooks this development entails. This comprehensive report offers an in-depth forecast of the market size over the next five years, enabling stakeholders to align strategies and optimize operations effectively.
Equipped with this knowledge, industry experts can gain a competitive edge, leveraging this detailed analysis to inform decision-making processes. Complementing the report, additional specific data and expert assistance are readily available, ensuring that professionals have access to precise and actionable insights without incurring extra charges.
For a deeper dive, all report data can be accessed in Excel format upon request, providing a versatile tool for robust investment decisions and accurate valuations. This flexibility ensures that financial assessments and strategic planning are grounded in the most up-to-date information.
As the Molecular Diagnostics at Point of Care market continues to evolve, staying informed and prepared is more critical than ever. This report serves as an essential resource for organizations looking to harness these market developments and drive forward-thinking strategies in the healthcare domain.
Key Topics Covered:
1 Market Guides1.1 Strategic Situation Analysis1.2 Guide for Executives, Marketing and Business Development Staff1.3 Guide for Management Consultants and Investment Advisors2 Introduction and Market Definition2.1 What are Molecular Diagnostics at the Point of Care?2.2 The Diagnostics Revolution2.3 Market Definition2.4 Methodology2.5 Perspective: Healthcare Spending3 Instrumentation, Automation and Diagnostic Trends3.1 Instrumentation and Automation3.1.1 Traditional Automation and Centralization3.1.2 The New Automation, Decentralization and Point Of Care3.1.3 Instruments Key to Market Share3.1.4 Bioinformatics Plays a Role3.1.5 PCR Takes Command3.1.6 Next Generation Sequencing Fuels a Revolution3.1.7 NGS Impact on Pricing3.1.8 Whole Genome Sequencing, A Brave New World3.1.9 Companion Diagnostics Blurs Diagnosis and Treatment4 Industry Overview4.1 Players in a Dynamic Market4.1.1 Academic Research Lab4.1.2 Diagnostic Test Developer4.1.3 Instrumentation Supplier4.1.4 Chemical/Reagent Supplier4.1.5 Pathology Supplier4.1.6 Independent Clinical Laboratory4.1.7 Public National/regional Laboratory4.1.8 Hospital Laboratory4.1.9 Physicians Office Lab (POLS)4.1.10 Audit Body4.1.11 Certification Body4.2 The Clinical Laboratory Market Segments4.2.1 Traditional Market Segmentation4.2.2 Laboratory Focus and Segmentation4.3 Industry Structure4.3.1 Hospital Testing Share4.3.2 Economies of Scale4.3.2.1 Hospital vs. Central Lab4.3.3 Physician Office Lab's4.3.4 Physician's and POCT5 Profiles of Key MDx Companies5.1 Abbott Laboratories5.2 Abionic5.3 Accelerate Diagnostics5.4 Access Bio5.5 Ador Diagnostics5.6 ADT Biotech5.7 Akonni Biosystems5.8 Alveo Technologies5.9 Anitoa5.10 Applied BioCode5.11 Aureum Diagnostics5.12 Aus Diagnostics5.13 Autonomous Medical Devices5.14 Baebies5.15 Beckman Coulter Diagnostics (Danaher)5.16 Becton, Dickinson and Company5.17 Binx Health5.18 Biocartis5.19 BioFire Diagnostics (bioMerieux)5.20 bioMerieux Diagnostics5.21 Bio-Rad Laboratories, Inc5.22 Bosch Healthcare Solutions GmbH5.23 Cepheid (Danaher)5.24 Credo Diagnostics Biomedical5.25 Cue Health5.26 Curetis (OpGen)5.27 Detect5.28 Diagenode Diagnostics (Hologic)5.29 Diasorin S.p.A.5.30 DNAe5.31 Domus Diagnostics5.32 Enzo Biochem5.33 Eurofins Scientific5.34 Fluxergy5.35 Fusion Genomics.5.36 Genedrive5.37 Genetic Signatures5.38 GenMark Dx (Roche)5.39 Genomadix5.40 Getlabs5.41 Global Access Diagnostics5.42 Grip Molecular Technologies5.43 Hologic5.44 Immunexpress5.45 Inflammatix5.46 Invetech5.47 Iollo5.48 J&J Innovative Medicine5.49 Karius5.50 Lucira Health (Pfizer)5.51 LumiraDx5.52 Maxim Biomedical5.53 Meep5.54 Meridian Bioscience5.55 Millipore Sigma5.56 Molbio Diagnostics5.57 NanoDx5.58 Nanomix5.59 Novacyt5.60 Novel Microdevices5.61 Novus Diagnostics5.62 Nuclein5.63 OnsiteGene5.64 Operon5.65 OraSure Technologies5.66 Oxford Nanopore Technologies5.67 Panagene5.68 Prenetics5.69 Primerdesign (Novacyt)5.70 Prominex5.71 Proof Diagnostics5.72 Qiagen5.73 QuantuMDx5.74 QuidelOrtho5.75 R-Biopharm AG5.76 Response Biomedical5.77 Revvity5.78 Roche Diagnostics5.79 Salignostics5.80 SD Biosensor5.81 Seegene5.82 Sekisui Diagnostics5.83 Siemens Healthineers5.84 Sona Nanotech5.85 SpeeDx5.86 T2 Biosystems5.87 Talis Biomedical5.88 Thermo Fisher Scientific5.89 Uniogen5.90 Veramarx5.91 Veredus Laboratories5.92 XCR Diagnostics5.93 Zhejiang Orient Gene Biotech6 Market Trends6.1 Factors Driving Growth6.1.1 New Genotypes Creating New Markets6.1.2 Aging Population a Boon for All Diagnostics6.1.3 Developing World Driving ID Dx Growth6.1.4 Point of Care - Why Centralization is Losing Steam6.1.5 Self Testing6.1.6 The Need for Speed6.2 Factors Limiting Growth6.2.1 Lower Costs6.2.2 Infectious Disease is Declining6.2.3 Wellness Hurts6.2.4 Economic Growth improves Living Standards7 Molecular Dx - Infectious Disease Recent Developments7.1 Recent Developments - Importance and How to Use This Section7.1.1 Importance of These Developments7.1.2 How to Use This Section7.2 Cubit Dx Secures Funding for High-Sensitivity, Low-Cost Platform7.3 Roche receives FDA clearance for STI at POC7.4 Smartphone-Enabled Platform Transforms POC Testing7.5 Credo Preps MDx System, Multiplex Respiratory Test for US Launch7.6 A low-cost CRISPR-based paper strip test for flu7.7 AMDI Receives Award to Develop 10 Minute POC Respiratory Panel7.8 Roche to Acquire LumiraDx Point-of-Care Testing Tech7.9 DiaSorin to Deliver Updated Instruments, New Assays in 2024/257.10 ReadyGo Diagnostics, Gemina Labs Expand MDx Pact7.11 DiagMetrics Developing Breath Assays7.12 Fortis Life Sciences Acquires IPOC7.13 Domus Diagnostics Wins NIH RADx Tech Contract7.14 Llusern Scientific to Launch POC MDx UTI Panel7.15 Altratech Enters POC MDx Testing Space with Unique Tech7.16 BioMerieux SpotFire MDx POC System Leverages Novel Approach7.17 Katalyst Labs to Distribute ProtonDx Dragonfly Rapid IVD System7.18 LEX Diagnostics Developing Ultra-Fast Low-Cost PCR7.19 Sherlock Biosciences Adds to Infectious Disease Dx Toolkit7.20 NanoDx Prepares for Point-of-Care Commercialization7.21 Paragraf to Study New POC Test to Guide Antibiotic Selection7.22 MicroGEM to Expand 30-Minute RT-PCR System7.23 Startup Detect to Roll Out Next-Gen Molecular Instrument7.24 Diagnostics for the Real World Third-Generation POC Platform7.25 Salignostics Closes Funding Round7.26 Cue Health Targets DTC Market in 20227.27 Grip Molecular Developing Home Respiratory Panel7.28 Mainz Biomed Developing Home ColoAlert Assay7.29 MFB Fertility Closes Series A Financing Round7.30 Home Test Company Prenetics to go Public7.31 Roche to Acquire TIB Molbiol to Expand Infectious Disease Portfolio7.32 BforCure Preparing Multiple Panels for Point-of-Care qPCR Platform7.33 Talis Biomedical Discusses Point-of-Care7.34 Roche to Acquire GenMark Diagnostics for $1.8B7.35 Pandemic Pushes Handheld qPCR Devices Closer to Commercialization7.36 Hologic to Acquire Mobidiag7.37 Lucira Health Focuses on User Friendly Approach to Home Testing7.38 Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO7.39 Fluidigm Plans 'Durable' Diagnostics, Clinical Business7.40 Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M7.41 Mammoth Biosciences Developing Pathogen Detection Tech7.42 Illumina, IDbyDNA Developing Sequencing-Based Respiratory Tests7.43 Scanogen Developing 90 Minute Infection Test7.44 Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection7.45 FDA Provides Self Testing SARS-CoV-2 EAU Guidance7.46 Mammoth Biosciences Announces Rapid, CRISPR-Based COVID-19 Diagnostic7.47 Genetic Signatures Gets CE Mark for Coronavirus Molecular Test7.48 Qiagen Respiratory Panel with Coronavirus Receives CE Mark7.49 Lumos Diagnostics Closes $15M Series A Funding
For more information about this report visit https://www.researchandmarkets.com/r/vbcfje
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
30 minutes ago
- Business Insider
World Bank restores funding to Uganda despite controversial anti-gay law
The World Bank has restored funding to Uganda nearly two years after suspending new financing in response to the country's Anti-Homosexuality Act (AHA). The World Bank has resumed funding to Uganda after a two-year suspension instigated by the Anti-Homosexuality Act (AHA). The Bank justified resumption through effective mitigation measures within ongoing Ugandan projects to limit potential adverse impacts. While Uganda's AHA remains unchanged, the decision signals shifting geopolitical dynamics by international financial institutions. The World bank in 2023, suspended funding to Uganda after the country's parliament passed the Anti-Homosexuality Act (AHA), saying the law contradicted its values. The legislation sparked international condemnation for imposing severe penalties on LGBTQ+ individuals, including life imprisonment and, in some cases, the death penalty. According to Reuters, the World Bank said it had developed a working relationship with Ugandan authorities to implement strong measures aimed at mitigating potential harm resulting from the law. " We have now determined the mitigation measures rolled out over the last several months in all ongoing projects in Uganda to be satisfactory," " Consequently, the Bank has prepared three new projects in sectors with significant development needs – social protection, education, and forced displacement/refugees, which have been approved by the Board." said a Bank spokesperson, who requested anonymity. The decision to resume funding signals a shift in the Bank's engagement strategy with Uganda and raises broader questions about how global institutions navigate the tension between promoting human rights and maintaining development partnerships. While there has been no indication of changes to Uganda's legal position on LGBTQ+ rights, the World Bank's renewed support may reflect wider geopolitical and economic considerations in the region. How the world reacted to Uganda's Anti-Gay Law Uganda's Anti-Homosexuality Act (AHA), signed into law in May 2023, imposed sweeping criminal penalties for same-sex relationships, including life imprisonment and, in cases of so-called 'aggravated homosexuality,' the death penalty. The law drew swift and widespread condemnation from Western governments, human rights organizations, and international institutions, and was widely regarded as one of the harshest anti-LGBTQ+ laws in the world. Beyond the World Bank's suspension of funding, several Western governments issued strong rebukes and implemented measures affecting Uganda's international standing. The United States led the diplomatic response, with the Biden administration describing the law as 'a tragic violation of universal human rights.' In turn, Washington imposed travel restrictions on Ugandan officials believed to be involved in the legislation and initiated a review of its financial assistance to the country. The European Union also condemned the law, emphasizing its incompatibility with international human rights norms and warning that it would reassess its relationship with Uganda. Similarly, the UN High Commissioner for Human Rights called the legislation 'shocking' and 'discriminatory,' urging its immediate repeal. Outside of official government action, Western-based human rights organizations, NGOs, and civil society groups amplified the global outcry. Advocacy campaigns were launched to pressure the Ugandan government, while some multinational corporations voiced concern about the law's potential impact on employees and business operations in the country. Despite this international backlash, Ugandan officials have welcomed the recent restoration of World Bank funding, portraying it as an endorsement of the country's sovereignty and development agenda.
Yahoo
34 minutes ago
- Yahoo
Clinical Laboratory Molecular Diagnostics for Infectious Disease Market Research 2025-2029: Biotechnology and Genomics Drive Advancements, Impact of Multiplex Assays in Diagnosis and Treatment
Discover the future of the Molecular Diagnostics - Infectious Disease sector with our comprehensive report. Explore how multiplex assays and rapid testing are transforming diagnosis and treatment amidst the boom in biotechnology and genomics. This detailed analysis covers dynamic trends such as pathogen evolution, globalization, and climate change impacts. Benefit from extensive insights, including U.S. Medicare Fee Schedules, and detailed global data. Equip your organization with expert knowledge today. Dublin, June 06, 2025 (GLOBE NEWSWIRE) -- The "Clinical Laboratory Molecular Diagnostics for Infectious Disease Markets 2025-2029: Strategies, Trends, and Forecasts by Application, Place and Country with Market Analysis & Executive Guides" report has been added to offering. The Molecular Diagnostics - Infectious Disease sector of the clinical diagnostics industry is poised for further growth. A market that just keeps on growing but is becoming more complex and segmented. Find out what's happening in this informative report - and find out about the impact of multiplex assays which threaten to change diagnosis and treatment forever. The report has hundreds of pages of information including a complete list of Current United States Medicare Fee Payment Schedules to help sharpen your pricing along with the most frequently used and billed tests. The report includes detailed breakouts for 15 countries and 4 regions. A detailed breakout for any country in the world is available to purchasers of the report. This research makes you the expert in your organization. Assistance and additional specific data is provided without additional charges. All report data is available in Excel format on request. Exciting technical developments especially in the seesaw between nucleic acid testing and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication. Infectious disease testing directly benefits from the explosion in biotechnology, especially genomics. Learn all about it in this report. A range of dynamic trends are pushing market growth and company valuations. Trends like: Multiplex testing Pathogen evolution and pandemics Biotechnology advances in genetics Climate change Globalization The rise of rapid testing Key Topics Covered: 1 Market Guides1.1 Situation Analysis2 Introduction and Market Definition2.1 Market Definition2.1.1 Market Size2.1.2 Currency2.1.3 Years2.2 Methodology2.2.1 Methodology2.2.2 Sources2.2.3 Authors2.3 Perspective: Healthcare Spending2.3.1 Global Healthcare Spending2.3.2 Spending on Healthcare and Pharmaceuticals2.3.3 Spending on Diagnostics2.3.4 Important Role of Insurance for Medical Services2.4 The Nature of the IVD Product2.4.1 Features Overview2.4.2 The Misunderstood Feature2.4.3 Regulation2.4.4 The Newest Feature2.4.5 The Oldest Feature2.4.6 All About Scope2.4.7 Why Turnaround is Becoming More Important2.4.8 The Role of Trust2.5 The IVD Product of the Future3 Infectious Diseases - Guide to the Pathogens3.1 Infectious Disease Pathogens - The Big Picture3.1.1 Viruses3.1.2 Bacteria3.1.3 Fungi3.1.4 Parasites3.1.5 Prions3.1.6 Virulence3.1.7 Transmission3.2 The Coronavirus3.2.1 Severe acute respiratory syndrome (SARS)3.2.2 Middle East respiratory syndrome (MERS)3.2.3 COVID-19. The SARS CoV 2 Virus3.2.3.1 Signs and symptoms3.2.3.2 Transmission3.2.3.3 Diagnosis3.2.3.4 Prevention3.2.3.5 Management3.2.3.6 Prognosis4 Industry Overview4.1 Players in a Dynamic Market4.1.1 Academic Research Lab4.1.2 Diagnostic Test Developer4.1.3 Instrumentation Supplier4.1.4 Chemical/Reagent Supplier4.1.5 Pathology Supplier4.1.6 Independent Clinical Laboratory4.1.7 Public National/regional Laboratory4.1.8 Hospital Laboratory4.1.9 Physicians Office Lab (POLS)4.1.10 Audit Body4.1.11 Certification Body4.2 The Clinical Laboratory Market Segments4.2.1 Traditional Market Segmentation4.2.2 Laboratory Focus and Segmentation4.2.3 Segmenting the Syndromic Testing Market4.3 Industry Structure4.3.1 Hospital Testing Share4.3.2 Economies of Scale4.3.3 Hospital vs. Central Lab4.3.4 Physician Office Lab's4.3.5 Physician's and POCT5 Market Trends5.1 Factors Driving Growth5.1.1 The Nucleic Acid Impact5.1.2 Population Dynamics5.1.3 The Developing World5.1.4 Decentralization5.1.5 Self Testing5.1.6 The Need for Speed5.2 Factors Limiting Growth5.2.1 Costs and Experience Curve Effects5.2.2 The Role of ID Prevalence5.2.3 Wellness5.2.4 The Impact of Living Standards5.3 Instrumentation, Automation and Diagnostic Trends5.3.1 Traditional Automation and Centralization5.3.2 The New Automation, Decentralization and Point of Care5.3.3 Instruments Key to Market Share5.3.4 Bioinformatics Plays a Role5.3.5 PCR Takes Command5.3.6 Next Generation Sequencing Fuels a Revolution5.3.7 NGS Impact on Pricing5.3.8 Whole Genome Sequencing, A Brave New World5.3.9 Companion Diagnostics Blurs Diagnosis and Treatment6 Clinical Laboratory MDx Infectious Disease Recent Developments6.1 Recent Developments - Importance and How to Use This Section6.1.1 Importance of These Developments6.1.2 How to Use This Section6.2 Presymptom Health Nabs Funding for Sepsis Test6.3 FDA Clears BioMerieux GI Panel6.4 Rapid Infection Diagnostic Launches BSIDx6.5 Biotia's AI-, Sequencing-Based UTI Test approved6.6 Delve Bio, Broad Clinical Labs Partner for Metagenomic6.7 Roche Respiratory Panel Receives FDA EUA6.8 Genetic Signatures Gets Approval for GI Parasite Panel6.9 Diasorin Expands Respiratory Panel6.10 BioMerieux Outlines MDx-Driven Growth6.11 T2 Biosystems Gets Extended T2Bacteria Panel6.12 Diasorin Aims to Deliver Updated Instruments, New Assays6.13 Oxford Nanopore Nabs Investment From BioMerieux6.14 Day Zero Diagnostics Closes Financing Round6.15 Spindiag Seeks Investors for Rapid PCR System6.16 Sorrento Therapeutics Nabs Contract for Dx Platform6.17 Kephera Planning Menu of Infectious Disease Tests6.18 Oxford Nanopore and BioMerieux to Develop IDDx6.19 SD Biosensor Eyes Global Expansion6.20 Selux Dx Next Gen Phenotyping Gets FDA Clearance6.21 Takara Developing High-Throughput Multiplex Panels6.22 BioGX Debuts New Point-of-Care Molecular Testing System6.23 Nanopath MDx Platform Providing 15-Minute Results6.24 ProtonDx Commercializing Rapid MDx Instrument6.25 Hologic Obtains CE Mark for MDx Epstein-Barr, BK Virus Assays6.26 Pathogenomix Infectious Disease Platform Uses Cloud-Based Analytics, NGS6.27 Accelerate Diagnostics Anticipates Growth6.28 Lumos Diagnostics Expanding Test Portfolio6.29 Study Validates Karius Cell-Free DNA to Detect Hundreds of Pathogens7 Key Companies7.1 Abbott Laboratories7.2 Agilent7.3 Altona Diagnostics7.4 Anitoa7.5 Autonomous Medical Devices7.6 Beckman Coulter Diagnostics (Danaher)7.7 Becton, Dickinson and Company7.8 BioGX7.9 Biomatik7.10 bioMerieux Diagnostics7.11 Bio-Rad Laboratories, Inc.7.12 Cepheid (Danaher)7.13 Diasorin S.p.A.7.14 DNAe7.15 Flow Health7.16 Global Access Diagnostics7.17 Great Basin Scientific, Inc.7.18 Hologic7.19 Novacyt7.20 Novus Diagnostics7.21 Oncimmune7.22 One Codex7.23 OraSure Technologies7.24 Prometheus Laboratories7.25 Qiagen7.26 QuidelOrtho7.27 R-Biopharm AG7.28 Response Biomedical7.29 Revvity7.30 Roche Diagnostics7.31 Siemens Healthineers7.32 Thermo Fisher Scientific7.33 Vela Diagnostics7.34 Veredus Laboratories7.35 YD Diagnostics7.36 Zhejiang Orient Gene Biotech8 The Global Market for Clinical Laboratory MDx Infectious Disease8.1 Global Market Overview by Country8.2 Global Market by Application - Overview8.3 Global Market by Place - Overview9 Global Clinical Laboratory MDx Infectious Disease Markets - By Application9.1 Respiratory9.2 Blood Borne Virus9.3 Transplant9.4 Hospital Acquired Infections9.5 Reproductive Health9.6 C19 Singleplex9.7 Meningitis9.8 Gastrointestinal9.9 Tropical10 Global Clinical Laboratory MDx Infectious Disease Markets - By Place10.1 Hospital Lab10.2 Outpatient Lab10.3 Point of Care10.4 Other Place11 Appendices11.1 Growth of Approved IVD Test Menu11.2 Growth of Approved Average IVD Test Fee11.3 The Most Used IVD Assays11.4 The Highest Grossing Assays11.5 Laboratory Fees Schedule For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Yahoo
34 minutes ago
- Yahoo
2025 Aromatherapy and Essential Oils Market Analysis Report: Holistic-Well-Being, Transparency, Sustainable Practices, Certifications and Claims, and AI-Powered Personalized Scents
The Global Aromatherapy and Essential Oils Market is poised for substantial growth, with a forecasted CAGR over 6%, driven by heightened well-being awareness and social media influence. Valued at over $8 billion in 2024, North America leads with 45% market share, fueled by holistic wellness trends. Asia-Pacific follows closely, propelled by demographic changes and Gen Z's health focus. Companies prioritizing personalized, natural solutions will thrive. The comprehensive report includes market size, revenue forecasts, trends, and more. Dublin, June 06, 2025 (GLOBE NEWSWIRE) -- The "2025 Aromatherapy and Essential Oils Market" report has been added to offering. The Global Aromatherapy and Essential Oils Market is set for consistent growth, with a projected CAGR exceeding 6% during 2024-2031 This expansion is driven by a growing emphasis on well-being, the rise of the she economy, the influence of social media, direct selling model and the increasing adoption of complementary and alternative medicine. The global market was valued over $8 billion in 2024. North America made up the largest portion of the global market with over 45% in revenues in 2024, followed by Asia Pacific with over 40% of revenues. The North American market is being driven by growing consumer interest in holistic wellness and natural remedies. As people become more focused on mental and emotional health, essential oils are being used for anxiety relief, stress management, and mindfulness. The rising awareness of sleep hygiene has also fueled demand for essential oil blends that promote relaxation and better sleep. Wellness brands are responding by offering more specialized products. The Asia-Pacific region is witnessing significant demographic and lifestyle shifts that are reshaping the wellness industry. Two primary factors driving this transformation are the aging population and the growing health-consciousness of younger generations like Gen Z. These changes are boosting the demand for products and services focusing on overall well-being. As European consumers continue to prioritize personalized and natural wellness solutions, the aromatherapy and essential oils market is poised for sustained growth. Companies that align their product lines with specific consumer needs, while emphasizing safety, sustainability, and quality, will remain competitive in this evolving landscape. Report Scope A comprehensive analysis of the Global Aromatherapy and Essential Oils Market for North America, Latin America, Europe, Asia-Pacific, and Rest of World, which includes market sizing, market share by competitor, drivers, restraints, regional trends and revenue forecasts to 2031. Essential oils are defined as natural oils, typically obtained by distillation, having the characteristic fragrance from the plant or other source extraction. Technically, aromatherapy means the use of aromas as therapy or the use of aromas for their healing properties. However, there is an increasing move to use the term 'essential oils' (which more accurately describes the existing market) as the therapeutic use of essential oils based on their aroma and properties, which includes internal use of the oils. For purposes of this research, only essential oils that are used for health and wellness and relaxation purposes via topical application, inhalation, diffusion, and ingestion have been included. The report includes the following information: Market Size, Growth Rate, Revenue Forecast (2024-2031) Revenue Share by Segment (distribution channel, product type, customer segment) Growth Drivers & Restraints Competitive Factors Industry Challenges Market Trends Regional Trends Pricing Trends Distribution Trends Regulatory Information Major Company Profiles Every report purchase comes with 1 hour of Analyst Inquiry Time for a phone call with the analysts. This can be used for strategic advice, consultation, or addressing issues in your business and linking them to a solution. Analyst Inquiry Time must be used within 45 days of report purchase. Key Topics Covered: 1. Research Scope, Methodology, Definition 2. Executive Summary Major Data Points - Global Revenue by Region, 2024 Revenue, Global, 2019-2024 3. Competitive Factors 4. Consumer Behavior 5. Market Drivers and Impact 6. Market Restraints and Impact 7. Global Trends Holistic-Well-Being Transparency Sustainable Practices Certifications and Claims AI-Powered Personalized Scents 8. Market Data - Global Total Market Revenue and Forecast Market Share by Company Distribution Share Analysis Market Share by Product Type 9. Competitive Landscape dOTERRA International, LLC Young Living Essential Oils, LC Melaleuca, Inc. 10. North America Major Data Points Consumer Behavior Market Drivers and Impact Market Restraints and Impact Market Trends Market Data 11. Asia-Pacific Major Data Points Consumer Behavior Market Drivers and Impact Market Restraints and Impact Market Trends Major Markets - China, South Korea, Japan, and Australia Market Data 12. Europe Major Data Points Consumer Behavior Market Drivers and Impact Market Restraints and Impact Market Trends Major Markets - Germany, and United Kingdom Market Data 13. Latin America Major Data Point Consumer Behavior Market Drivers and Impact Market Restrains and Impact Market Trends Market Data 14. Market Data - Rest of the World Companies Featured doTERRA Young Living Melaleuca Inc. Ryohin Keikaku Co. Ltd. Plant Therapy Neal's Yard Remedies Jurlique Saje Natural Business Inc. Frontier Co-op (Aura Cacia) Rocky Mountain Oils Eden Botanicals Melaleuca Plant Therapy rareEssence Eden Gardens Essential oils Nature Packaged Swiss Just America Exotic Aroma Perfect Potion Essentials Quintis @aroma Primavera Life GmbH First Natural Brands (Tisserand) Farfalla Terra Gaia Florihana Neom well-being Aromatherapy Associates Absolute Aromas For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
